4//SEC Filing
Lavelle Erin 4
Accession 0001209191-23-035857
CIK 0001404644other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:25 PM ET
Size
5.7 KB
Accession
0001209191-23-035857
Insider Transaction Report
Form 4
Lavelle Erin
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-08+25,000→ 25,000 totalExercise: $0.79Exp: 2033-06-07→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the total shares monthly beginning July 8, 2023 until the option is fully vested on June 8, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001737613
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:25 PM ET
- Size
- 5.7 KB